|
Volumn 89, Issue 4, 2002, Pages 451-461
|
Evaluation of the involvement of nitric oxide and substance P in reducing baroreflex gain in the genetically hypertensive (GH) rat.
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
DITERPENE;
ENZYME INHIBITOR;
N(G) NITROARGININE METHYL ESTER;
NEUROKININ 1 RECEPTOR;
NITRIC OXIDE;
NITRIC OXIDE SYNTHASE;
NITROPRUSSIDE SODIUM;
NOLPITANTIUM;
PHENYLEPHRINE;
PIPERIDINE DERIVATIVE;
QUINUCLIDINE DERIVATIVE;
RESINIFERATOXIN;
SUBSTANCE P;
VASOCONSTRICTOR AGENT;
VASODILATOR AGENT;
ANIMAL;
ARTICLE;
BLOOD PRESSURE;
DRUG ANTAGONISM;
DRUG EFFECT;
GENETICS;
HEART RATE;
HYPERTENSION;
MALE;
METABOLISM;
PATHOPHYSIOLOGY;
PRESSORECEPTOR REFLEX;
RAT;
REST;
SPONTANEOUSLY HYPERTENSIVE RAT;
ANIMALS;
BAROREFLEX;
BLOOD PRESSURE;
DITERPENES;
ENZYME INHIBITORS;
HEART RATE;
HYPERTENSION;
MALE;
NG-NITROARGININE METHYL ESTER;
NITRIC OXIDE;
NITRIC OXIDE SYNTHASE;
NITROPRUSSIDE;
PHENYLEPHRINE;
PIPERIDINES;
QUINUCLIDINES;
RATS;
RATS, INBRED SHR;
RECEPTORS, NEUROKININ-1;
REST;
SUBSTANCE P;
VASOCONSTRICTOR AGENTS;
VASODILATOR AGENTS;
|
EID: 1842866624
PISSN: 0231424X
EISSN: None
Source Type: Journal
DOI: 10.1556/APhysiol.89.2002.4.5 Document Type: Article |
Times cited : (9)
|
References (0)
|